GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » NonCurrent Deferred Liabilities

Genenta Science SPA (Genenta Science SPA) NonCurrent Deferred Liabilities : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Genenta Science SPA's non-current deferred liabilities for the quarter that ended in Dec. 2023 was $0.00 Mil.

Genenta Science SPA NonCurrent Deferred Liabilities Historical Data

The historical data trend for Genenta Science SPA's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA NonCurrent Deferred Liabilities Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
NonCurrent Deferred Liabilities
- - - - -

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only - - - - -

Genenta Science SPA NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genenta Science SPA (Genenta Science SPA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » NonCurrent Deferred Liabilities
Comparable Companies
RVPH VXRT PMVP THRX ANIX IFRX BDTX ABEO CDXC INO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
K5F:Germany
Address
Via Olgettina No. 58, Milan, ITA, 20132
Website
https://www.genenta.com
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.